Literature DB >> 2867862

Serious complications of sulfasalazine.

R K Pearl, R L Nelson, M L Prasad, C P Orsay, H Abcarian.   

Abstract

Whereas minor side effects of sulfasalazine are common, serious adverse reactions to this drug generally are considered rare. However, this report discusses three major complications of sulfasalazine that occurred within the past three years, one resulting in the death of a patient. As more patients with inflammatory bowel disease are being managed by physicians of various disciplines, it is important to become familiar with the potentially dangerous side effects of all medications prescribed. For this reason, a brief review of the pharmacology, clinical use, and toxicity of sulfasalazine is presented.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867862     DOI: 10.1007/bf02555026

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  3 in total

1.  The three week sulphasalazine syndrome.

Authors:  H Brooks; H G Taylor; F E Nichol
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

Review 2.  Inflammatory bowel disease.

Authors:  G M Van Rosendaal
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

3.  Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis.

Authors:  Moein Eskandari; Fereshteh Asgharzadeh; Mohammad Mostafa Askarnia-Faal; Hamideh Naimi; Amir Avan; Mitra Ahadi; Hassan Vossoughinia; Masoumeh Gharib; Atena Soleimani; Niloufar Naghibzadeh; Gordon Ferns; Mikhail Ryzhikov; Majid Khazaei; Seyed Mahdi Hassanian
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.